BridgeMD
Tests treatment safety and results for Meralgia Paresthetica
Official title The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica
ClinicalTrials.gov ID: NCT07328360
What this study is testing
- What it's testing
- The management of MP typically follows a conservative pathway, encompassing patient education, lifestyle modifications (e.g., avoidance of tight garments, weight loss), pharmacotherapy (such as neuropathic pain agents or corticosteroid injections), and physical therapy. However, evidence supporting the efficacy of these interventions is largely anecdotal or derived from low-quality studies, and a substantial proportion of patients experience persistent symptoms refractory to standard care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18-65 years.
- Clinical diagnosis of MP (based on history: burning pain, tingling, numbness in the lateral thigh; tenderness over the inguinal ligament near the...
- Symptoms persistent for at least 3 months (chronic).
- A baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
You likely can't join if
- Secondary MP (e.g., due to pelvic surgery, trauma, or tumor mass effect confirmed by imaging).
- Significant lumbar radiculopathy (L1-L2).
- Coagulopathy, use of anticoagulants.
- Pregnancy.
- Skin disease or infection in the treatment area.
- Presence of a cardiac pacemaker.
See the full eligibility criteria
- Adults aged 18-65 years.
- Clinical diagnosis of MP (based on history: burning pain, tingling, numbness in the lateral thigh; tenderness over the inguinal ligament near the anterior superior iliac spine (ASIS); and a positive pelvic compression...
- Symptoms persistent for at least 3 months (chronic).
- A baseline pain intensity of ≥4 on the Numeric Rating Scale (NRS).
- Secondary MP (e.g., due to pelvic surgery, trauma, or tumor mass effect confirmed by imaging).
- Significant lumbar radiculopathy (L1-L2).
- Coagulopathy, use of anticoagulants.
- Pregnancy.
- Skin disease or infection in the treatment area.
- Presence of a cardiac pacemaker.
- Severe cognitive impairment.
The study team makes the final eligibility decision.
Where it's taking place
- Uşak, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uşak, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.